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to taste. The strong taste of the egg, along with 
the spicing, effectively masked the taste of 
clozapine. 
One and a half years have elapsed since 
the inception of this novel method of 
administration of clozapine, and the patient 
continues to maintain the improvement that he 
had initially shown. 
DISCUSSION 
This case highlights four important issues: 
1.Scrambled egg, along with salt and pepper, 
effectively masks the taste of clozapine. This, 
therefore, is a practical method for the 
surreptitious administration of medication to a 
noncompliant patient. 
2. The above notwithstanding, it is unethical and 
illegal to treat a patient without his knowledge; 
this holds true even when the family members of 
the patient themselves undertake the 
responsibility for the act. Legally, an unwilling 
patient can be treated against his will only if 
committed to psychiatric care through 
appropriate judicial processes. 
3. It is particularly wrong to surreptitiously treat 
patients with clozapine because blood monitoring 
for granulocytopenia and agranulocytosis 
becomes difficult to effect. Current 
recommendations are that patients be monitored 
weekly for the initial 6 months, and once in two 
weeks thereafter (Physicians Desk Reference, 
1999). In the case of the present patient, the 
family took a calculated risk against medical 
advice, weighing the approximately 0.5% risk of 
agranulocytosis against the benefits afforded by 
clozapine. 
4. That the family readily obtained clozapine 
without a medical prescription is an damning 
indictment of the system of drug availability 
in the country. There is a pressing need for 
greater ethical practice amongst pharmaceutical 
dispensers. 
Interestingly, the surreptitious 
administration of clozapine has been reported 
from other countries as well (Pereira et al., 1999). 
The* practice of administering medication in food 
and drink may be widespread in settings such 
as long stay facilities for the elderly (Treolar et 
al., 2000). In this contest, Treolar et al. (2001) 
discussed ethical and related issues, and 
suggested recommendations on the subject. 
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Association of personality disorders with 
tattooing, though previously reported, is mostly 
limited to antisocial personality disorder (Raspa 
& Cusack, 1990). A case of repetitive tattooing, a 
kind of self-mutilatory behaviour, is described in a 
patient with borderline personality disorder with 
comorbid obsessive-compulsive disorder (OCD). 
A 52-year-old single white male was 
admitted to the Veteran's Administration Hospital, 
Pittsburgh, USA, with a history of obsessive-
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compulsive symptoms of 15 years duration. He 
had obsessive doubts and fear of dirt and 
contamination while his compulsions included 
hand washing, checking and counting. His score 
on the Yale-Brown Obsessive-Compulsive Scale 
(YBOCS) at intake was 27. Prior to the onset of 
OCD, he had a checkered premorbid history being 
characterized by a chronic feeling of boredom and 
emptiness, inability to express intense emotions 
appropriately, unstable relationships and overt 
sensitivity to rejection, low self esteem and 
nicotine dependence interspersed with episodes 
of self-injurious and parasuicidal acts. This 
account was consistent witn a DSM-IV diagnosis 
of borderline personality disorder (BPD). His 
tattoos antedated the OCD, the first being at the 
age of 30 years. His first tattoo was an impulsive 
act, the motive being to project a more masculine 
image to counter feelings of inadequacy. Following 
this, the frequency of tattooing gradually 
increased to an extent that he was visiting the 
tattoo professional three times a month 
culminating in 102 tattoos till his present 
admission. He continued with this activity in spite 
of severe inflammation on one instance for which 
he had to be hospitalized. The patient knew that 
this behaviour was excessive, but he always 
justified it with a motive and never tried to resist 
it. His earlier motive of donning a stronger look 
was replaced by a drive to avoid boredom, which 
later changed to alleviating the anxiety of OC 
symptoms. Over the last two years, following the 
death of his mother and his father being diagnosed 
with Alzheimer's disease, he developed an 
additional motive for his tattooing which was now 
a way to grieve his mother's loss and distract 
himself from facing the reality of his father's 
impending death. 
Besides tattooing, the patient indulged in 
other acts of self-mutilation like breaking his bones 
on two occasions. On not finding the pain from 
tattooing of sufficient threshold to regulate his 
emotions, one day he impulsively decided to stab 
himself in the calf, which prompted his present 
involuntary admission. He was treated with 
naltrexone (100 mg/day) in addition to sertraline 
(100 mg/day), which he was receiving for OCD. 
Within two days of starting naltrexone, his self-
injurious urges disappeared but he still was not 
willing to give up tattooing. Even after a week, his 
OC symptoms, however, showed no change with 
the YBOCS score remaining at 27. 
This, to our knowledge, is the first case, 
describing compulsive tattooing in a patient with 
borderline personality disorder with comorbid 
obsessive-ccmpulsive disorder. Tattooing has been 
associated with DSM-IV cluster B personality 
disorders, especially the antisocial and the 
borderline personality disorder, with only 
anecdotal reports of the latter (Raspa & Cusack, 
1990; Inch & Huws, 1993). However, in none of 
these cases tattooing as a repetitive phenomenon 
was documented. 
Tattooing has been viewed as an act of self-
mutilation (Raspa & Cusack, 1990), the latter 
being a characteristic of borderline personality 
disorder. The noteworthy aspect of this case is 
that tattooing initially represented an act of self-
mutilation in consonance with the underlying 
personality disorder. However, later it became 
repetitive and had a 'compulsive' quality to it, though 
not a true compulsion by definition. There are rare 
reports of self-mutilation taking on a compulsive 
pattern but this mostly occurs with cutting and 
burning acts (Gardener & Cowdry, 1985) and we 
are aware of only a single report of compulsive 
tattooing in a patient with OCD (without comorbid 
personality disorder) (Caplan et al., 1996). 
A question worth exploring is whether in 
this patient OCD 'coloured' the presentation of 
tattooing, which was initially a part of BPD. 
Hollander regards OCD and BPD as spectral 
disorders with OCD being at the compulsive end 
and the BPD at the impulsive end (Hollander, 
1999). Moreover, these conditions may have a 
common biological denominator, namely 
dysfunctional serotonergic system, as indicated 
by the response of selective serotonin reuptake 
inhibitors in both these conditions (Hollander, 
1999). An interesting observation was that 
tattooing in this patient provided some relief from 
OC symptoms, a hypothesis, which has been 
cited by a study (McKay et al., 2000). The authors 
indicated an affect-regulating role of self-mutilation 
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in OCD with the emergence of OC symptoms 
associated with remission in self-mutilation 
episodes. Thus, the effect of comorbid OCD on 
the acts of self-mutilation of BPD requires more 
thought. 
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RATIONAL USE OF PSYCHOTROPIC DRUGS 
BY GENERAL PRACTITIONRES 
Sir, 
There has been a drastic change in the field 
of psychopharmacology in the last fifty years.The 
1 
specific drugs with specific mechanisms of action 
are available for different mental ailments. Though 
this scenario has helped the specialists but has 
made the job of general practitioners difficult. 
The current concept of integration of mental 
health in primary health care has made the role of 
general practitioners more important.About60% 
of the patients with a psychiatric disorder are 
identified and receive treatment in a primary care 
setting (Regier et al., 1978). Similar data has been 
reported from our country (Parikh,2001).Hence it 
becomes imperative to involve general 
practitioners in mental health programmes for 
better and quality management of psychiatric 
disorders.Appropriate drug should be selected 
from the group indicated for that condition. 
Selecting one drug from a group, one should keep 
following in mind.The knowledge of drug 
pharmacodynamics and pharmacokinetics, 
adequate dose.adequate duration,indications and 
contraindications.adverse effectsjnteraction profile 
of drug,addictive potential of drug.co morbid 
physical/ psychiatric disorder ,use in special 
population like children, elderly, pregnancy, 
Lactation and polypharmacy. Although all these 
factors are interrelated but one should give due 
consideration to all before selecting a drug. 
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